Fact CheckerSign in

NCT05871749Completed

Effects of Hepatic Fibrosis on Hepatic Steatosis Using the Ultrasound Attenuation Imaging in Chronic Hepatitis B

Effects of Hepatic Fibrosis on Quantifying Hepatic Steatosis Using the Ultrasound Attenuation Imaging in Patients With Chronic Hepatitis B: a Prospective Study

Source: ClinicalTrials.gov · Last updated 31 Jul 2024

Brief summary (registry, in English)

The investigator aimed to prospectively study the effect of the hepatic fibrosis on quantifying hepatic steatosis using ultrasound attenuation imaging (ATI value) in patients with chronic hepatitis B.

Status (registry)
Completed
Study type
Observational
Enrollment
120 (actual)
First submitted
10 May 2023
Start date
7 Jun 2023
Primary completion date
16 Feb 2024
Lead sponsor
So Yeon Kim
Diseases
Hepatitis B
NCT number
NCT05871749

What you commit to

  • Study type: Observational
  • Participants enrolled: 120
  • From 7 Jun 2023 to the primary completion date, 16 Feb 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Who underwent liver transplantation or right hemihepatectomy

Other illness

  • High bleeding risk patients

Other

  • Huge hepatic mass or numerous cysts in right hepatic lobe, who is not eligible for measuring ultrasound attenuation imaging and Fibroscan

Who the study is looking for

  • Chronic hepatitis B patients
  • Who is scheduled for pathological exam such as liver biopsy or surgery, that can quantify hepatic steatosis and hepatic fibrosis
  • Who submitted informed consent

Age in the registry: 18 years to 79 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Asan Medical Center
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.